Of the 25 fusions not identified in RNA, 13 matched the characteristic tumor type of the known fusion pair (nine of which were TMPRSS2-ERG fusions in prostate cancer) and are likely to be pathogenic but with insufficient expression to be detected in the RNA. This evidence concerns the gene ERG and Familial prostate cancer.